CIBC World Markets’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-13,279
Closed -$60.2K 1716
2025
Q1
$60.2K Buy
+13,279
New +$70.3K ﹤0.01% 1684

Other funds holding HCAT

CIBC World Markets's HCAT Position: Q2 2025 in Review

CIBC World Markets sold out of Health Catalyst (HCAT) in Q2 2025, closing a stake of 13,279 shares — an estimated $60.2K sold.

CIBC World Markets first reported a position in HCAT in Q1 2025 and held it in 1 quarter. The position peaked at $60.2K in Q1 2025. 145 funds tracked by Wall St. Rank hold HCAT as of Q2 2025.

  • CIBC World Markets reported no remaining Health Catalyst position as of Q2 2025 after selling out during the quarter.
  • CIBC World Markets sold 13,279 Health Catalyst shares in Q2 2025, an estimated $60.2K.
  • CIBC World Markets first reported a position in Health Catalyst in Q1 2025 and held it in 1 quarter.
  • CIBC World Markets's Health Catalyst position peaked at $60.2K in Q1 2025.
  • 145 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2025.

Based on CIBC World Markets's 13F filing for Q2 2025, filed 14 Aug 2025.